NSE
Zydus Lifesciences LimitedZYDUSLIFE
Zydus Lifesciences is a diversified pharma company.
| Key products | Generics, specialty, vaccines, consumer wellness (Nycil, Glucon-D). |
|---|---|
| Geography | India, US, emerging markets. |
| Competitors | Sun Pharma, Cipla, Dr Reddy's. |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
1 · tilt Bullish
Next corporate action
Dividend - Re 1 Per Share
ex 2026-07-24
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | CIPLA | +₹1,527.1 Cr | 39 | — | — | +19 | 44 |
| 2 | MANKIND | +₹445.9 Cr | 38 | — | — | — | — |
| 3 | ALKEM | +₹103.5 Cr | 33 | — | — | -2 | 6 |
| 4 | ZYDUSLIFEThis | +₹0 Cr | 1 | 1 | +1 | — | — |
| 5 | DRREDDY | +₹0 Cr | 4 | — | — | +20 | 46 |
| 6 | SUNPHARMA | +₹0 Cr | 6 | — | — | +15 | 45 |
| 7 | TORNTPHARM | +₹0 Cr | 2 | — | — | — | — |
| 8 | LUPIN | +₹0 Cr | 4 | — | — | — | — |
| 9 | AUROPHARMA | +₹0 Cr | 2 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-07-24ActionDividend - Re 1 Per ShareDividend
- 2026-06-16FilingZydus Lifesciences Limited has informed the Exchange about General UpdatesGeneral
- 2026-06-16FilingZydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 16, 2026, titled "ZydM&A
- 2026-06-11FilingZydus Lifesciences Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-09FilingZydus Lifesciences Limited has informed the Exchange about General UpdatesGeneral
- 2026-05-29ActionBuy BackBuyback
- 2025-07-25ActionDividend - Rs 11 Per ShareDividend
- 2024-08-30BulkSELL · ₹756 CrUBS PRINCIPAL CAPITAL ASIA LIMITED
- 2024-08-30NetDay net −₹756 Cr
- 2024-07-26ActionDividend - Rs 3 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2
- 8
- 1
- 2
1 deals · 2024-08-30 → 2024-08-30
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2024-08-30 | UBS PRINCIPAL CAPITAL ASIA LIMITED | HNI / other | SELL | ₹756 Cr |
1 deal in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on ZYDUSLIFE
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.